Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: keflex / cefepime attending: chief complaint: weight loss major surgical or invasive procedure: none history of present illness: mr. is an 84yom with h/o cll treated with multiple regimens admitted from clinic due to concern about potential infection in the setting of progressive fatigue and weight loss. pt states that he feels his energy level is about the same, although his wife notes that he has been sleeping 20/24 hours daily for the past week. per clinic records, he has also had 7-8lb weight loss over the past week. his wife has been encouraging increased caloric intake at home. he also notes worsening of his urinary urge incontinence over the past few weeks. he describes the incontinence as sensing the urge to urinate and then voiding a small amount of urine before he can reach the bathroom. he has been planning to see urology as an outpatient but has not yet scheduled an appointment. . of note, pt has been dedicated to his career as a patent lawyer for 50 years and was recently asked to retire by his law firm. . ros is otherwise negative. he denies fevers/chills, night sweats, ha, visual changes, dizziness, cough, cp/sob, abdominal pain, n/v, dysuria, diarrhea/constipation, melena, brbpr, numbness/tingling of extremities. past medical history: oncologic history: : diagnosed with cll : 6 cycles of fludarabine : 4 cycles of rituxan/fludarabine : 4 cycles of r-cvp : 4 cycles of r-chop : 1 cycle cytoxan/rituxan : 1 cycle of r-chop : 1st cycle of fcr : 2nd cycle of fcr : enrolled in protocol 08-052 a phase i open label multiple-dose, dose-escalation study of mdx-1342 in patients with cd19 positive refractory/relapsed chronic lymphocytic leukemia. received 4 doses, last dose : fludarabine/cytoxan : fludarabine/cytoxan/ rituxan : cycle 1 bendamustine : cycle 2 bendamustine/rituxan : cycle 3 bendamustine (80 mg/m2 days 1&2) : cycle 4 bendamustine (80 mg/m2 days 1&2) : cycle 5 bendamustine (80 mg/m2 days 1&2) and rituxan. : cycle 6 bendamustine (80 mg/m2 days 1&2) and rituxan . past medical history: - cll (see above) - bladder stones-->cystoscopic removal-->e coli sepsis described in d/c summary from - hypertension - bronchiectasis and asthma, followed for both by dr . - hearing loss - macular degeneration - bph social history: the patient lives with his wife and dog, was working as a patent lawyer until 2 weeks ago when he retired. denies tobacco use, alcohol use, or drug use. he is founding partner of a large patent law firm, the largest in that deals with biomedical and technological patents. he has two sons. family history: his mother died of colon cancer at years and his father died at 62 of a stroke (in context of hypertension). physical exam: vs: t 98.6 bp 106/58 hr 80 rr 20 o2sat 99%ra gen: thin, fatigued-appearing elderly male with flat affect heent: perrl, eomi, mmm, sclera anicteric, oropharynx clear without lesions neck: supple, r soft 1cm submandibular node, soft subcentimeter l cervical nodes lungs: ctab no wheezes/rhonchi/rales cardiac: rrr nl s1 s2 no m/r/g abdomen: soft, ntnd +bs extremities: wwp no clubbing/cyanosis/edema neuro: aaox3, cn ii-xii grossly intact, 5/5 strength, sensation grossly intact, ftn intact pertinent results: admission labs: 09:07am blood wbc-1.3* rbc-3.04* hgb-10.1* hct-27.9* mcv-92 mch-33.3* mchc-36.3* rdw-17.4* plt ct-103* 05:35am blood neuts-71* bands-0 lymphs-11* monos-13* eos-0 baso-3* atyps-1* metas-1* myelos-0 09:07am blood urean-47* creat-1.6* na-135 k-5.0 cl-104 hco3-18* angap-18 05:35am blood alt-26 ast-35 ld(ldh)-472* alkphos-105 totbili-1.3 05:35am blood calcium-7.7* phos-3.4 mg-2.2 acth stim test: 02:54pm blood cortsol-14.8 04:00pm blood cortsol-28.0* thyroid function: 09:07am blood tsh-3.6 discharge labs: 06:45am blood wbc-0.7* rbc-2.87* hgb-9.5* hct-27.0* mcv-94 mch-33.2* mchc-35.3* rdw-16.9* plt ct-101* 06:45am blood neuts-76* bands-0 lymphs-7* monos-14* eos-0 baso-0 atyps-2* metas-0 myelos-1* 06:45am blood glucose-107* urean-45* creat-1.2 na-130* k-4.8 cl-103 hco3-18* angap-14 06:45am blood ld(ldh)-502* 06:45am blood calcium-8.6 phos-4.2 mg-2.4 imaging: pet ct : interpretation: comparison is made to ct ab/pelvis , and ct torso . head/neck: no fdg avid lymph nodes are present in the neck. anatomic imaging of the neck is limited by streak artifact. chest: numerous left axillary lymph nodes are present, the largest measures 22mm, but is not fdg avid (image 47), and appears larger than in when the largest node measured up to 18mm. a 13mm non-fdg avid left para-tracheal lymph node is present. no fdg avid lymph nodes are present. abdomen/pelvis: the spleen is enlarged measuring 17cm, but is not fdg avid. a 19 x 9cm conglomeration of lymph nodes in the mid-abdominal mesentery is not fdg avid above background, and appears little changed since the prior study. bilateral para-aortic lymph nodes and numerous pelvic mesentery nodes are present that are not fdg avid and appear little changed. bilateral enlarged inguinal non-fdg avid lymph nodes appear little changed. a focus of fdg uptake along the right pelvic sidewall localizes to muscle (image 146). musculoskeletal: no suspicious bone lesions are preset and there is no abnormal fdg uptake. physiologic uptake is seen in the brain, myocardium, salivary glands, gi and gu tracts, liver and spleen. impression: 1. conglomeration of mesenteric lymph nodes that is not fdg avid and appears little changed to only minimally increased since . 2. non fdg avid lymphadenopathy in the mediastinum, para-aortic region, pelvic mesentery and bilateral inguinal regions appears little changed. brief hospital course: primary reason for hospitalization: 84yom with h/o cll treated with multiple regimens admitted from clinic due to progressive fatigue and weight loss. active issues: # fatigue/weight loss: the etiology of his progressive fatigue and weight loss was unclear. initially there was concern for transformation of his cll to lymphoma, however pet-ct showed no e/o disease. he was also evaluated for possible adrenal insufficiency given his lab abnormalities of hyponatremia and hyperkalemia, but stim test was normal. given his normal results and no evidence of infection, it was felt that he could be discharged home with plans to continue work-up as outpatient. chronic issues: # cll: pt is currently week #5 of campath. his campath is currently held until infectious workup is complete. # urinary urge incontinence: pt has chronic urge incontinence which has worsened recently, possibly his general weakness. bladder scan showed small volume residual. he will follow up with urology as an outpatient. # asthma: stable. he was continued on his home albuterol/atrovent, serevent. transitional issues: - no medications were changed during hospitalization. - the following labs were pending at discharge: acth and aldosterone, bk virus, hhv6, final blood cx. - he was scheduled to f/u in heme/ clinic on . medications on admission: acyclovir 400 mg tablet 1 (one) tablet(s) by mouth twice a day albuterol sulfate 90 mcg hfa aerosol inhaler - 2 puffs inh every six (6) hours as needed for shortness of breath or wheezing albuterol sulfate 2.5 mg/3 ml (0.083 %) solution for nebulization - 2.5 mg(s) inhaled via nebulizaiton 2-3 times a day as needed for shortness of breath or wheezing allopurinol 100 mg tablet - 1 tablet(s) by mouth once a day finasteride 5 mg tablet - 1 tablet(s) by mouth daily fluconazole 100 mg tablet - 1 tablet(s) by mouth once a day ipratropium bromide 17 mcg/actuation hfa aerosol inhaler - 2 hfa(s) inhaled every six (6) hours as needed for shortness of breath or wheezing lidocaine 5 % (700 mg/patch) adhesive patch, medicated - apply to affected area 12 hours per day apply to affected area 12 hour on, and remove for 12 hours. salmeterol 50 mcg disk with device - 1 whiff inhaled twice a day sulfamethoxazole-trimethoprim 400 mg-80 mg tablet - 1 (one) tablet(s) by mouth once a day tamsulosin 0.4 mg capsule, ext release 24 hr - 1 capsule(s) by mouth twice a day 1/2 hour after a meal medications - otc acetaminophen 500 mg tablet - 1 tablet(s) by mouth twice a day guaifenesin - dosage uncertain omega-3 fatty acids 1,000 mg capsule - 1 capsule(s) by mouth daily vit c-vit e-copper-znox-lutein 226 mg-200 unit- mg-0.8 mg-34.8 mg capsule - 1 (one) capsule(s) by mouth twice a day discharge medications: 1. acyclovir 400 mg tablet sig: one (1) tablet po q12h (every 12 hours). 2. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: two (2) puffs inhalation q6h (every 6 hours) as needed for sob/wheezing. 3. allopurinol 100 mg tablet sig: one (1) tablet po daily (daily). 4. finasteride 5 mg tablet sig: one (1) tablet po daily (daily). 5. fluconazole 100 mg tablet sig: one (1) tablet po q24h (every 24 hours). 6. ipratropium bromide 0.02 % solution sig: one (1) neb inhalation q6h (every 6 hours) as needed for sob/wheezing. 7. lidocaine 5 %(700 mg/patch) adhesive patch, medicated sig: one (1) patch topical once a day: 12hrs on 12hrs off. 8. salmeterol 50 mcg/dose disk with device sig: one (1) whiff inhalation q12h (every 12 hours). 9. sulfamethoxazole-trimethoprim 400-80 mg tablet sig: one (1) tablet po daily (daily). 10. tamsulosin 0.4 mg capsule, ext release 24 hr sig: one (1) capsule, ext release 24 hr po bid (2 times a day): 1/2 hr after meal . 11. acetaminophen 325 mg tablet sig: 1-2 tablets po q6h (every 6 hours) as needed for pain. discharge disposition: home discharge diagnosis: cll metabolic acidosis hyponatremia discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: dear mr. , you were admitted to the hospital with progressive fatigue and weight loss. while here, we did a pet scan to look for advancement of your cll. the results of the scan were negative. we also found that your sodium levels were low, which can be a sign of adrenal insufficiency, however a cortisol stimulation test was negative. we think that your current symptoms may be secondary to your chemotherapy medication. we think that it is safe for you to go home and follow up in the hematology/ clinic for your scheduled appointment. . we have not made any changes to your home medications. followup instructions: department: hematology/bmt when: monday at 9:00 am with: , rn building: sc clinical ctr campus: east best parking: garage department: bmt chairs & rooms when: monday at 9:00 am department: hematology/bmt when: wednesday at 8:30 am with: , rn building: sc clinical ctr campus: east best parking: garage procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours parenteral infusion of concentrated nutritional substances other endoscopy of small intestine other electric countershock of heart percutaneous abdominal drainage percutaneous abdominal drainage percutaneous abdominal drainage injection or infusion of immunoglobulin diagnoses: acidosis hyperpotassemia thrombocytopenia, unspecified acute kidney failure with lesion of tubular necrosis unspecified pleural effusion unspecified essential hypertension acquired coagulation factor deficiency hyposmolality and/or hyponatremia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pulmonary collapse paroxysmal ventricular tachycardia chronic kidney disease, stage iii (moderate) hypotension, unspecified alkalosis unspecified hearing loss macular degeneration (senile), unspecified other ascites chronic obstructive asthma with (acute) exacerbation hyperosmolality and/or hypernatremia bronchiectasis without acute exacerbation cytomegaloviral disease other alteration of consciousness chronic lymphoid leukemia, without mention of having achieved remission neutropenia, unspecified enteritis due to other viral enteritis other fluid overload edema of male genital organs fever presenting with conditions classified elsewhere other specified disorders of adrenal glands hypothermia not associated with low environmental temperature other calculus in bladder urge incontinence 

Answer: The patient is high likely exposed to